Hotel Kompas
Borovška cesta 100
4280 Kranjska gora
Slovenija

Registration & Abstract submission
January 15, 2010

Registration fee payment
February 15, 2010

Final Programme
March 1, 2010

Contact

Conference secretary

Phone: +386 1 4769 604
Fax: +386 1 4258 031
Email: ceto@nib.si

PDF
natisni
E-pošta
List of posters

Posters should be displayed all the time during the conference. Presenting authors should be at posters during poster sessions on Thursday, March 25, 20:30 - 22:00 (posters 1 - 23) and Friday, March 26, 20:30 - 22:00 (posters 24 - 56).

List of posters:

P1. Q. An: Influence of oxygen on biological function in CD133-expressing glioma cells

P2. Petra Avanzo: Cnispin, trypsin-specific inhibitor from the basidiomycete

Clitocybe nebularis 

P3. Mojca Bizjak: Protective nutrition and cancer

P4. Vladimir B. Bregar: Agglomeration of nanoparticles for drug delivery in

different physiological solutions

 P5. Anja Bubik: Cyclic cyanopeptides and cell signaling in tumour cell lines in

vitro

P6. Maruška Budič: Cloning and expression of Phaseolus vulgaris L. drought-

responsive protease genes

P7. Miha Butinar: The role of cysteine cathepsins inhibitor in tumour

progression and metastasis

P8. Roberta Castino: The oncosuppressor and autophagy modulator PTEN

regulates multidrug resistance in ovarian cancer

P9. Petra Cerkovnik: Class C CpG ODNs in combination with tumour

irradiation creates a unique in situ tumour vaccine 

P10. Sophie Chabot: LNA-based oligos delivery by electropulsation

P11. Chiara Compagnin: PEGylated liposomes for the delivery of hydrophobic

photosensitizers

P12. Jasmina Živa Černe: Hormone replacement therapy use and other generallyrecognized breast cancer risk factors among Slovenian postmenopausal

women

P13. Tanja Dolinšek: Effect of siRNA molecules targeting endoglin on endoglinexpression level and cell viability in a human microvascular endothelial cell

line in vitro

 P14. Patrick F. Forde: Combined immunogene therapy and regulatory T-cells

inactivation in treatment of weakly immunogenic solid tumours

 P15. Kivanc Gorgulu: Analysis of tobacco mosaic virus(TMV) on primary(Colo-320) and metastatic (Colo-741) human colon cancer cells treated

with α-lactalbumin or sulindac

P16. Saša Haberl: Visualization of DNA-cell interaction during gene

electrotransfer for different Mg!+ ion concentrations

P17. Anja Hafner: The role of γ1-syntrophin in regulating γ-enolase-mediated

neurotrophic effect  

P18. Julija Hmeljak: Survivin expression in malignant pleural mesothelioma

P19. Rosana Hudej: The bioassay media for electroporation in vitro

P20. Vid Janša: Number of microvesicles in patients with gastrointestinal

stromal tumours treated by imatinib

P21. Jure Jelenc: Sonoporation of mouse melanoma cells B16-F1 with

microbubbles

P22. Saša Kenig: Endothelial cells increase invasiveness of glioblastoma cells via

SDF-1, cathepsin B and MMP9

P23. Tatyana A. Khalikova: Lysosomal cathepsins B, L, and D in murine

experimental leukemias

 

 

 

 

 

P24. Slavko Kralj: Binding of monoclonal antibodies onto the silica-coated

fluorescent magnetic nanoparticles

P25. Petra Kramarič: Electrochemotherapy as a single and adjuvant treatment

of cutaneous tumours in horses

P26. Simona Kranjc: The effect of antioxidants on electrotransfection efficiency

in the C2C12 cell line in vitro and in mouse muscle tibialis cranialis in vivo

P27. Zaynah Maherally: Hyaluronic acid (CD44) and polio virus (CD155)

receptors: expression and role in glioma invasion

P28. Barbara Mali: Influence of electrochemotherapy of internal tumours on

electrocardiogram

P29. Boštjan Markelc : The effect of electroporation on normal blood vessel

permeability in mice

P30. Cécil J. W. Meulenberg: Electrochemotherapy of cultured human

microvascular endothelial cells in vitro

P31. Francesca Moret: In vitro cellular responses elicited by PEGylated

ORMOSIL nanoparticles

P32. Gabriela Panter: Cancer immunotherapy by constitutively active Toll-like

receptor 4

P33. Urša Pečar Fonović: Cathepsin S shedds transmembrane chemokine

fractalkine: a brain microglia/neuronal cells co-culture model

P34. Jana Petković: TiO! nanoparticle induced DNA damage and alterations inexpression of DNA damage responsive genes in human hepatoma HepG2

cells

P35. Marko Pezdirc: Genotoxicity and bioactivation of 2-amino-1-methyl-6-

phenylimidazo[4,5-b]pyridine (PhIP) in HepG2 cells

P36. Jure Pohleven: Inhibitory action of a lectin from mushroom Clitocybe

nebularis on human leukemic T cells

P37. Sara Prijič: Increased internalization of superparamagnetic nanoparticles

into malignant cells by an external magnetic field

P38. Monika Primon: The change of protease expression profile during hMCS

spontaneous transformation has an influence on TMC’s characteristics

P39. Anja Pucer: Differential expression of the full set of human secretory

phospholipases A2 in breast cancer cell lines

P40. Gorazd Pucihar: Experimental investigation of electroporation pulse

equivalent parameters

P41. Matija Rojnik: Targeted PLGA and PEG-PLGA nanoparticles for

improving photodynamic therapy in cancer

P42. Aleš Sedlar: Radiosensitizing effect of intratumoural mIL-12 electrogene

therapy on murine sarcoma 

P43. Mojca Stražišar: Gene expression profiling of non-small cell lung cancer

P44. Petra Sušanj: The temperature effect on number of microvesicles from

peripheral blood

P45. Alja Štraser: The cianobacterial hepatotoxin nodularin induces DNA

damage and reactive oxygen species formation in HepG2 cells

P46. Tine Thursion: A new assay for the measurement of the liberated domain Iof the urokinase receptor in plasma improves the prediction of survival in

colorectal cancer

P47. Ana Torkar: Design and synthesis of selective cathepsin L activity based

probes (ABP)

P48. Mireille Treeby: The role of endocytosis in uptake of nucleic acid molecules

after electrotransfection of cells

P49. Nina Trošt: Recombinant human erythropoietin (rHuEPO): Mechanism

of transcription activation in breast cancer cell lines

P50. Metka Volavšek: Significant up-regulation of NPC1 in colorectal and lung

adenocarcinoma

P51. Abigail Frances Welford: Preventing TIE!+ macrophage infiltration incombination with vascular-disrupting agents may enhance the treatment

of solid tumours

P52. Irena Zajc: Xanthohumol induces differential cytotoxicity and triggers

apoptotic pathways in normal astrocytes and in glioblastoma cells

P53. Svetlana  Zhanaeva: Relationship between the sensitivity to theinduction of apoptosis in mice lymphosarcoma cells and cysteine protease

activity in tumour tissue

P54. Daša Zupančič: Uroplakin expression and apical plasma membranestructure in low grade papillary urothelial tumours induced by N-butyl-N-

(4-hidroxybutyl)nitrosamine in rats

P55. Valerija Žager: Development of cell-based biosensor systems for detection

of genetic damage

P56. Anže Županič: Method of treatment planning for electrochemotherapy of

deep-seated tumour lesions

P57. Urška Tajnšek: Systems biology approach for cellular therapy of pancreatic cancer